公司資料
Evogene 股價、新聞與催化劑
- 股票代碼:
- EVGN
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- Israel
股票表現
0.56 USD (-6.79%)
收盤價
最後更新: 2026年8月17日
6.14M USD
市值
股價為何變動
As of Aug 17, 2026, EVGN closed down 6.79% at $0.5600. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Evogene is a computational biology and platform company focused on using data science to design biological products across agriculture and life sciences. Its business is more about biological engineering than drug development.
所在地與產業分類
Evogene is headquartered in Israel and listed on NASDAQ. It sits in biotechnology tools and computational biology.
商業模式特徵
The company depends on platform adoption, strategic partnerships, and the ability to monetize computational biology across multiple end markets. Investors watch collaborations, platform breadth, and commercial execution.
生技產業定位
Evogene occupies a platform-biology niche rather than a classic therapeutics role. It matters to the broader biotech ecosystem because it enables biological design and discovery.
未來催化劑
- Evogene’s catalysts are platform execution across ag-biotech and pharma discovery, plus any update that shows its computational biology approach can keep producing value. The market will watch whether the platform remains relevant.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。